Truist has initiated coverage of Larimar Therapeutics (NASDAQ:LRMR) with a buy rating, citing an "asymmetric" risk/reward ahead of regulatory updates for its drug candidate nomla for Friedreich ...

To expand his research on patients with Friedreich's ataxia, Bidichandani is collaborating with David R. Lynch, M.D., Ph.D., of Children's Hospital of Philadelphia, who shares a portion of the grant.

Friedreich’s ataxia appears in the teenage years with balance and walking problems and can lead to heart issues, vision and hearing loss, and other symptoms. The disorder is inherited, caused by ...

Session ID: 2025-05-02:8f3912a8e89c700fbf07bfb0 Player Element ID: V1a92bad6_4471_4d5b_86c3_0e32123c1dcb_6369445265112 ...

Lexeo Therapeutics has posted updated data in Friedreich ataxia (FA) patients, linking a gene therapy to improvements on outcomes the biotech plans to use as co-primary endpoints in a ...

In this video, Khalaf Bushara, MD, FRCP, highlights the greatest challenges in Friedreich's ataxia care and management.